AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial.
about
AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
AQ-13, an investigational anti ...... on-inferiority clinical trial.
@en
type
label
AQ-13, an investigational anti ...... on-inferiority clinical trial.
@en
prefLabel
AQ-13, an investigational anti ...... on-inferiority clinical trial.
@en
P2093
P2860
P921
P1476
AQ-13, an investigational anti ...... on-inferiority clinical trial.
@en
P2093
Ababacar Maiga
Aliou Sissako
Asif H Anwar
Boubakar Diallo
David M Mushatt
Donald J Krogstad
Frances J Mather
Haiyan D Miller
Jeffrey G Shaffer
Lansana Sangaré
P2860
P304
P356
10.1016/S1473-3099(17)30365-1
P577
2017-09-12T00:00:00Z